“Spooky Action at a Distance”: The Most Comprehensive Review Yet of Physiologic Neuromodulation for Limb Preservation #ActAgainstAmputation #Neuromodulation #SpinalCordStimulation #CLTI @BurnsTrauma @KeckSchool_USC @ResearchatUSC @USC

Einstein famously derided quantum entanglement as “spukhafte Fernwirkung” — spooky action at a distance. He could not accept that measuring one particle could instantaneously influence another, no matter how far apart. The idea offended his sense of how the universe should work.

We borrowed that phrase — and that productive skepticism — for what may be the most comprehensive review to date on a concept that has been quietly threading through our field for years: the idea that we can intervene at one site in the body and produce measurable physiologic effects at a completely different, distant site. Stimulate the spinal cord and improve microcirculation in the foot. Ping the spleen with focused ultrasound and alter the cytokine profile of a healing wound. Occlude a limb with a blood pressure cuff and enhance endothelial function somewhere else entirely. Cut a window in the tibia and watch new blood vessels sprout in ischemic tissue distally.

These are not metaphors. These are measurable, reproducible phenomena — and they converge on a shared set of downstream effects: enhanced microcirculation, angiogenesis, and anti-inflammatory signaling.

Our new paper, “Physiologic ‘Action at a Distance’: Neuromodulation, Neuroimmune Signaling, and Limb Preservation in Diabetic Foot Disease,” just published in Burns & Trauma (Oxford University Press, impact factor ~10), lays out the mechanistic architecture across five major modalities:

1. Spinal Cord Stimulation (SCS) — 10-kHz high-frequency SCS (the Senza system) has shown remarkable results in the SENZA-PDN trial: 79% of patients achieved 50% or greater pain relief versus 5% with conventional management alone. Perhaps even more striking, 62% showed neurological improvement at 6 months, with evidence of improved protective sensation — raising the tantalizing question of whether we can actually “regrow” sensory function.

2. Peripheral Focused Ultrasound (pFUS) — Splenic-targeted pFUS activates the cholinergic anti-inflammatory pathway, modulating TNF-alpha, IL-1-beta, and IL-6. In preclinical models, 3-minute daily ultrasound sessions produced 75% wound size reduction 4 days faster than placebo. Our pilot trial at the LA General Regional Burn Center is testing this in human burn wounds, with implications for DFUs and CLTI.

3. Remote Ischemic Conditioning (RIC) — The simplest and cheapest of the lot: a blood pressure cuff, cycles of occlusion and reperfusion. In Shaked et al., 41% complete healing versus 0% in placebo. In Regulski et al., 75.6% healed by week 20 versus 36.6% with standard care. The mechanism involves nitric oxide release, endothelial conditioning, and cytokine modulation — all triggered at a distance from the wound.

4. Tibial Transverse Transport (TTT) — Adapted from the Ilizarov technique, TTT uses mechanical distraction of a tibial cortex bone window to stimulate periosteal activation, osteopontin upregulation, and the Orai1/STIM1 calcium signaling pathway. The downstream effect: eNOS activation, nitric oxide release, neovascularization. In Liao et al., 100% wound healing was achieved in both arterial and non-arterial stenosis groups.

5. Lateral Tibial Periosteum Distraction (LTPD) — A less invasive cousin of TTT that achieves similar angiogenic effects through controlled periosteal tension without cortical bone cutting. In one case, ankle-brachial index improved from 0.5 to 0.9, and VAS pain dropped from 9 to 1.

The unifying framework here is not just that these therapies work — it is that they work through shared downstream biology despite having completely different proximal mechanisms. Neural pathways. Humoral signaling. Mechanical forces. Three roads, one destination: tissue repair at a distance.

This is what makes the Einstein metaphor apt. In quantum mechanics, entanglement was eventually proven real — it just required a new framework to understand it. In limb preservation, we are at a similar inflection point. These “spooky” distant effects are real. The question now is how to harness them systematically.

The paper also addresses what we do not yet know. Most of the evidence base is early-phase. Sample sizes are small. Protocols are heterogeneous. Long-term amputation-free survival data are largely absent. We need multicenter RCTs with standardized endpoints. We need head-to-head comparisons. We need cost-effectiveness data. We lay out a detailed research priority agenda.

But the conceptual shift matters. Diabetic foot disease is not a local wound problem. It is a systemic neurovascular and inflammatory disorder. And the most promising emerging therapies treat it that way — by engaging the body’s own regenerative and immunomodulatory pathways.

Congratulations to lead author Ahmed Sami Raihane and the entire team: Gabriela Morales Deusch, Charles Liu, Bijan Najafi, Wuquan Deng, and Natasha Dark. Published today in Burns and Trauma. This was a true interdisciplinary effort — surgery, neuroscience, neurosurgery, biomedical engineering, endocrinology — which is exactly how you attack a problem this complex.

Read the full open-access paper here: Raihane AS, Morales Deusch G, Liu C, Najafi B, Deng W, Dark NG, Armstrong DG. Physiologic “Action at a Distance”: Neuromodulation, Neuroimmune Signaling, and Limb Preservation in Diabetic Foot Disease. Burns & Trauma. 2026.

Related posts on this topic:

#ActAgainstAmputation #Neuromodulation #SpinalCordStimulation #DiabeticFoot #CLTI #RemoteIschemicConditioning #TibialTransport #SplenicStimulation #pFUS #WoundHealing #LimbPreservation #Angiogenesis #DiabeticNeuropathy #SpookyAction